Reducing our CO2 footprint, downsizing energy consumption and limiting our waste is a core part of our sustainability commitment and initiatives.
In 2020, we reviewed and revised our environmental goals to reflect the longer-term greenhouse gas reduction requirement to meet the Paris Climate Agreement. The Paris Climate Agreement sets out a global climate action plan to limit global warming to well below 2°C and is pursuing efforts to limit it to 1.5°C.
As an affiliate of the Ajinomoto group, Ajinomoto Bio-Pharma Services’ climate objectives are included in the SBTi group targets.
With our energy and greenhouse gas targets, we aim to reduce our CO2 emissions intensity to below 50% in 2030 (Scope baseline year 2019) and to become carbon neutral in 2050.
|Reduce energy consumption and promote production of climate neutral energy||Greenhouse Gases||Total amount of Scope 1 and Scope 2||Reference year of carbon footprint
|15% reduction||50% reduction||Carbon neutral|
|Scope 3||Reference year of carbon footprint||8% reduction||24% reduction|
|Renewable Energy Power Ratio||Start of RE100||10%||50%||100%|